In a study published today in the open-access journal The Lancet Global Health, the Drugs for Neglected Diseases initiative (DNDi) and other researchers report a persistent deficiency in truly new therapeutics for neglected diseases, despite nominal…
Source: Deadly gaps persist in new drug development for neglected diseases
Thursday, October 24, 2013
Deadly gaps persist in new drug development for neglected diseases
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment